VTGN

VTGN

USD

Vistagen Therapeutics Inc. Common Stock

$2.360-0.040 (-1.667%)

实时价格

Healthcare
生物技术
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$2.400

最高价

$2.498

最低价

$2.350

成交量

0.11M

公司基本面

市值

68.1M

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

0.13M

交易所

NCM

货币

USD

52周价格范围

最低价 $1.9当前价 $2.360最高价 $4.21

相关新闻

BusinessWire

Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025

Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called

查看更多
Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025
BusinessWire

Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year

Company's PALISADE-4 Phase 3 trial now expected to read out in the first half of 2026 Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry

查看更多
Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year
BusinessWire

Vistagen to Present at the 2025 American Society of Clinical Psychopharmacology Conference

Posters Highlight New Insights into Social Anxiety Disorder and the Novel Mechanism of Action of Itruvone to Treat Major Depressive Disorder Vistagen (NASDAQ:VTGN), a clinical-stage biopharmaceutical company pioneering

查看更多
Vistagen to Present at the 2025 American Society of Clinical Psychopharmacology Conference